MB

Mereo BioPharma

Biotechnology · London, England, United Kingdom · Founded 2015

About

They aim to improve the lives of patients with rare diseases by identifying and developing therapies with the greatest unrealized, long-term potential. They have a pipeline of therapeutics and offer valuable opportunities for investors. Research output of 1,000-2,000 works, primarily in Medicine, Agricultural and Biological Sciences, and Biochemistry, Genetics and Molecular Biology.

Company details may include data from People Data Labs, licensed CC BY 4.0.